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The genes encoding members of the wingless-related MMTV integration site (WNT) and fibroblast growth factor (FGF)
families coordinate growth, morphogenesis, and differentiation in many fields of cells during development. In the
mouse, Fgf9 and Wnt4 are expressed in gonads of both sexes prior to sex determination. Loss of Fgf9 leads to XY sex
reversal, whereas loss of Wnt4 results in partial testis development in XX gonads. However, the relationship between
these signals and the male sex-determining gene, Sry, was unknown. We show through gain- and loss-of-function
experiments that fibroblast growth factor 9 (FGF9) and WNT4 act as opposing signals to regulate sex determination. In
the mouse XY gonad, Sry normally initiates a feed-forward loop between Sox9 and Fgf9, which up-regulates Fgf9 and
repressesWnt4 to establish the testis pathway. Surprisingly, loss of Wnt4 in XX gonads is sufficient to up-regulate Fgf9
and Sox9 in the absence of Sry. These data suggest that the fate of the gonad is controlled by antagonism between
Fgf9 and Wnt4. The role of the male sex-determining switch—Sry in the case of mammals—is to tip the balance
between these underlying patterning signals. In principle, sex determination in other vertebrates may operate through
any switch that introduces an imbalance between these two signaling pathways.
Citation: Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, et al. (2006) Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4(6):
e187. DOI: 10.1371/journal.pbio.0040187
Introduction
The development of sexually dimorphic reproductive
organs is a common feature among animal species. The
testis and ovary represent two divergent pathways of
development from the bipotential embryonic gonad. The
switch that initiates divergent development of the gonad is
highly diverse among species; however, the underlying
mechanisms that lead to the establishment of ovary or
testis pathways are likely to be conserved. In all species, the
embryonic gonad is made up of a mixed population of
germ cells and somatic cells. This tissue is remarkable in
that all of its cells are believed to be bipotential, and can
differentiate into ovarian or testicular lineages [1,2].
Consistent with the idea that cells in this primordium are
poised between two developmental pathways, some of the
genes that are involved in establishing sexual dimorphism,
including Dax1 (dosage-sensitive sex reversal-congenital adrenal
hypoplasia critical region on the X chromosome protein 1), Sox9
(Sry-like HMG box 9), Fgf9 (fibroblast growth factor 9), and Wnt4
(wingless-related MMTV integration site 4), are initially ex-
pressed in similar patterns in XX and XY gonads [3–8]. The
conventional view of mammalian sex determination is that
the basic pathway of organ development is ovarian, and
that the testis-determining gene operates by diverting this
program toward testis development by simultaneously
inﬂuencing the fate of the key supporting cell lineage
and initiating a male-speciﬁc morphogenetic program. All
of the experimental evidence suggests that these two
processes are closely interwoven. For example, both
proliferation [9] and migration of cells to trigger testis
cord formation [10,11] appear to be closely integrated with
Sertoli cell differentiation.
Sry, a Y chromosome-linked gene, is the primary sex-
determining gene in mammals [12–14]. In the absence of Sry
expression—in XX embryos, or in XY embryos carrying a
deletion of Sry—cells in the gonad follow an ovarian differ-
entiation pathway. Genetic evidence from chimeric mice [15],
and expression studies using reporter transgenes [2,16],
indicate that Sry expression is required only in precursors
of the somatic supporting cell lineage. Expression of Sry in
these bipotential cells leads to their differentiation as testis-
speciﬁc Sertoli cells rather than as follicle cells, the parallel
cell type of the ovary [2]. It is believed that the Sertoli cell is
the ﬁrst cell type to differentiate in the gonad [17]. There is
substantial evidence that a critical threshold number of
Sertoli cells is required to establish testis differentiation
[9,15,18–20]. In cases where this threshold is not reached,
ovary differentiation ensues.
Once Sry expression begins, expression patterns of other
genes in the gonad begin to diverge. The ﬁrst gene
downstream of Sry known to show male-speciﬁc up-
regulation in Sertoli cell precursors is a related gene
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expressed in many tissues in the developing embryo, Sox9.
Disruption of Sox9 expression in the XY gonad causes male-
to-female sex reversal [21,22], whereas increasing the dose of
Sox9 in the XX gonad leads to testis development [23–25].
These studies indicate that Sox9 plays a central role in sex
determination. Unlike Sry, which is speciﬁc to mammals,
expression of Sox9 is known to be conserved in the gonad of
many species. In mammals, Sox9 is up-regulated immediately
after Sry expression initiates. Experiments tracing Sry-
expressing cells using a stable reporter demonstrated that
once testis differentiation is established, all Sertoli cells that
express Sox9 are descendants of cells that have expressed Sry
[16], suggesting that activation of Sox9 is a cell-autonomous
effect of Sry. However, mutations in several signaling
pathways including Fgf9 and Igf1r/Irr/Ir (insulin-like growth
factor 1 receptor/insulin receptor-related receptor/insulin receptor)
resulted in loss of Sox9 expression and partial or complete
sex reversal [26,27], suggesting that extracellular signaling
pathways play a signiﬁcant role during primary sex
determination.
Mice homozygous for a null mutation in Fgf9 display male-
to-female sex reversal caused by disruption of all testis-
speciﬁc cellular events, including cell proliferation, meso-
nephric cell migration, testis cord formation, and the
differentiation of Sertoli cells [26,27]. Fgf9, like many of the
founding signals in the gonads, is initially expressed in gonads
of both sexes, but becomes male-speciﬁc after Sry is ex-
pressed. In a reciprocal manner, expression of Wnt4, which is
also initially common to gonads of both sexes, becomes
female-speciﬁc [8]. XX gonads with a null mutation in Wnt4
display some obvious aspects of testicular differentiation [28].
Based on the theory that Sertoli cells initiate all downstream
testicular differentiation, this might imply that Sertoli
differentiation had been initiated in Wnt4/ XX gonads.
However, expression of Sertoli cell markers was not pre-
viously detected in these mutants during fetal stages [8,29],
leading to the conclusion that Wnt4 was not involved in
primary sex determination in the gonad.
To integrate these ﬁndings, we investigated the genetic
relationship of Sry, Sox9, Fgf9, and Wnt4 in the regulatory
network that governs the gonadal ﬁeld. We show that the
loss of Fgf9 in homozygous mutant XY gonads does not
affect the expression of SRY or the initial up-regulation of
SOX9; however, SOX9 expression is not maintained in the
Fgf9/ mutant gonads, and testis differentiation is aborted.
We also demonstrate that FGF9 represses the ovary-
promoting gene, Wnt4. We hypothesize that FGF9 functions
in a feed-forward loop to expand Sertoli precursor cells,
which secrete FGF9, to a critical threshold number
sufﬁcient to suppress Wnt4. This directly or indirectly
stabilizes SOX9 expression and secures the male fate of the
gonad. WNT4 seems to oppose the male pathway by
repressing expression of SOX9 and FGF9. Surprisingly,
both male pathway genes are transiently activated in
Wnt4/ XX gonads in the absence of the Y-linked gene
Sry. Based on this genetic and in vitro data, we suggest that
the plasticity of the bipotential gonad is controlled by
mutually antagonistic signals between FGF9 and WNT4 in
the gonadal ﬁeld. These signals coordinate sexually
dimorphic patterns of growth, morphogenesis, and cellular
differentiation.
Results
Early Bipotential Expression of FGF9 Resolves to an XY-
Specific Pattern by 12.5 dpc
Using an antibody speciﬁc to FGF9, we examined
expression during normal gonad development. FGF9 protein
was distributed throughout the 11.5 dpc gonad in both sexes
(Figure 1A and 1B). However, by 12.5 dpc, FGF9 was detected
only in XY gonads in two domains: in cells near the surface
of gonads and in cells located within testis cords. This sex-
speciﬁc expression pattern was maintained in gonads at 13.5
dpc (Figure 1C–1F). FGF9 expression within testis cords was
localized to Sertoli cells and excluded from germ cells based
on the germ cell membrane marker platelet/endothelial cell
adhesion molecule (PECAM) (Figure 1D and 1F). To conﬁrm
this result, we examined agametic gonads from KitW/Wv
compound heterozygous embryos, which develop testis cords
containing Sertoli cells only. FGF9 was detectable at normal
levels in testis cords in XY KitW/Wv gonads, where alkaline
phosphatase staining veriﬁed the absence of germ cells
(Figure 1G–1J), indicating that FGF9 is expressed by Sertoli
cells, and that its expression is not dependent on the
Figure 1. Stage- and Cell-Specific Expression of FGF9 in Embryonic
Gonads
(A–F) Detection of FGF9 protein (red) at different stages of gonad
development. FGF9 is up-regulated in XY gonads at 11.5 (B), 12.5 (D), and
13.5 dpc (F) while it is down-regulated in XX after 11.5 dpc (A, C, and E).
No signal was detected in XY Fgf9/ gonads (unpublished data).
(G–J) Serial sections of wild-type XX and compound heterozygous KitW/Wv
XY gonads stained for alkaline phosphatase (purple; G and I) and FGF9
(red; H and J). Testis cords are formed in the absence of germ cells in XY
KitW/Wv mutant gonads at 12.5 dpc (arrowhead in J). Expression of FGF9
is present in the mutant gonads where Sertoli cells are the only
remaining cell type in the cords (J). Semitransparent dotted line indicates
the boundary between gonad and mesonephroi. PECAM (green) marks
germ cells and vascular endothelial cells (C–F, H, and J). The scale bars
represent 25 lm.
g, gonad; m, mesonephroi.
DOI: 10.1371/journal.pbio.0040187.g001
PLoS Biology | www.plosbiology.org June 2006 | Volume 4 | Issue 6 | e1871001
Antagonistic Signals in Sex Determination
presence of germ cells. In summary, FGF9 expression was
present in both XX and XY gonads at bipotential stages, and
became restricted to XY gonads as testis differentiation
proceeded.
Sry Expression Is Normal in Homozygous Null Fgf9 XY
Gonads
The early expression of Fgf9 in bipotential gonads raised
the question of whether Fgf9 is an upstream regulator of Sry.
To investigate this possibility, we mated Fgf9þ/ mice with a
transgenic reporter line that carries an enhanced green
ﬂuorescent protein (EGFP) transgene driven by the Sry
promoter Sry-EGFP. At early stages, this transgene represents
the pattern of endogenous Sry expression [2]. The expression
of the EGFP reporter was detected in Fgf9/ XY gonads
comparable to Fgf9þ/ littermate controls (Figure 2A and 2B),
suggesting that transcriptional regulation of Sry is independ-
ent of Fgf9. Sex reversal is caused not only by the loss of
normal levels of Sry expression [30,31], but also by mutations
disrupting SRY import into the nucleus [32]. The transgene,
Sry-EGFP, does not reﬂect the intracellular distribution of
the SRY protein. To investigate this aspect of SRY
regulation, we bred Fgf9þ/ mice with another Sry reporter
mouse line carrying a Myc-tagged Sry transgene, SryMyc, which
recapitulates the endogenous intracellular SRY expression
pattern [16]. Using an antibody against c-MYC, the expres-
sion and nuclear localization of SRYMYC in SryMyc; Fgf9/
gonads was indistinguishable from littermate controls
(Figure 2C and 2D). These data using two different Sry
transgenic reporter lines provide evidence that Sry expres-
sion is not dependent on Fgf9. Therefore, Fgf9 signaling must
act in parallel and/or downstream of Sry to regulate testis
development.
FGF9 Can Up-Regulate SOX9 Expression
In our previous study we did not observe SOX9 expression
at 12.5 dpc in Fgf9/ XY gonads that fail to develop into
normal testes [26]. However, the loss of SOX9 expression at
12.5 dpc could be a consequence of the loss of Sertoli
differentiation rather than a reﬂection of the genetic
interaction between FGF9 and SOX9. Normally, Sox9 is
weakly expressed in wild-type genital ridges of both XX and
XY embryos at 10.5 dpc and, after the onset of Sry expression,
is up-regulated in XY gonads [5,33,16]. As results indicated
that Fgf9 functioned downstream of, or in parallel with Sry,
we investigated whether Fgf9 was involved in the up-
regulation of Sox9 expression. Primary cell culture and gonad
culture systems were used to assess Sox9 activation by
exogenous FGF9. For in vitro cell culture, cells were isolated
from 11.5 dpc gonads free of mesonephroi, and cultured on
extracellular matrix-coated coverslips with or without addi-
tion of puriﬁed FGF9 in culture media. After culture for 24 h,
SOX9 expression was monitored by an antibody speciﬁc to
SOX9 in XX cells and control XY cells. Exogenous FGF9
increased cell number in XX and XY cell cultures compared
with cells in a duplicate culture without FGF9 treatment
(unpublished data), and caused the up-regulation of SOX9 in
XX cells (Figure 2E–2H). Up-regulation of SOX9 had not
previously been seen in whole XX gonads cultured with
exogenous FGF9 [9]. To explain the difference between
experimental results from dissociated XX gonadal cells and
XX gonads, we reasoned that the local concentrations of
FGF9 might not be high enough to override blocking signals
in the intact XX gonad, or that active FGF9 was not
efﬁciently localized or presented in the extracellular matrix
of the XX gonad. To test the local effect of FGF9, we
modiﬁed the XX gonad culture by stably immobilizing FGF9,
or BSA as a control, on beads (Figure 2I–2K). Under these
conditions, SOX9 expression was up-regulated locally in cells
near the surface of the XX gonad in contact with the FGF9
bead (Figure 2K). Taken together, these in vitro data
demonstrate that ectopic FGF9 signaling can induce SOX9
expression in XX gonadal cells, suggesting a positive
interaction between Fgf9 and Sox9.
Figure 2. Epistatic Relationship of Sry, Fgf9, and Sox9
(A–D) Sry expression is not dependent on Fgf9. Fgf9þ/ (A) and Fgf9/ (B)
XY gonads at 11.5 dpc expressing GFP (green) from the Sry promoter
(polygonal cells, arrows). Blood cells show background fluorescence
(doughnut-shaped cells). Fgf9þ/ (C) and Fgf9/ (D) XY gonads at 11.5
dpc expressing SRYMYC protein (red, arrowheads). Inset shows nuclear
counterstain (green, Syto13) colocalizing with SRYMYC. PECAM (blue)
marks endothelial and germ cells. Scale bars represent 25 lm.
(E–K) Exogenous FGF9 can up-regulate SOX9 expression in XX gonads.
Immunostaining of SOX9 (green) in primary cultures of gonadal cells. XX
cells (E) and XY cells (G) cultured with exogenous FGF9 show induction
of SOX9 expression (F and H, respectively). Cells were counterstained
using the nuclear marker, Syto13 (red). Immunostaining of SOX9 (red) in
gonad explants cultured with BSA- or FGF9-coated beads. SOX9 is
expressed in XY gonads and cells contacting FGF9-coated beads (dotted
circle labeled ‘‘F’’) in XX gonads (I and K) but not in XX cells contacting
BSA-coated control beads (‘‘B’’) (J). PECAM (blue) marks endothelial and
germ cells. Scale bars (I–K) represent 50 lm.
DOI: 10.1371/journal.pbio.0040187.g002
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Fgf9 Is Required for Maintaining SOX9 Expression in XY
Gonads
To investigate whether Fgf9 is essential for the up-
regulation of Sox9 in vivo, we assessed SOX9 expression in
loss-of-function Fgf9þ/ and Fgf9/ XY gonads at 11.5–12.5
dpc (Figure 3A–3F). In wild-type and heterozygous mutant XY
gonads at 11.5 dpc, SOX9 was detected in a small number of
cells in the gonad (Figure 3A). Over the next 6 h of
development, nuclear SOX9 accumulated rapidly in cells
toward the cortex and the anterior and posterior poles of the
gonad, replicating patterns previously reported for both Sry
and Sox9 expression [2,16,34–36]. This unique pattern was
also observed in Fgf9/ XY gonads (Figure 3D and 3E).
Somatic cells within Fgf9/ gonads were positive for SOX9 at
11.5 dpc, the earliest stages examined, demonstrating that
initial expression and up-regulation of SOX9 were not
disrupted in Fgf9/ mutant XY gonads prior to 12.0 dpc.
Notably, in Fgf9/XY gonads, SOX9 was no longer detectable
by 12.5 dpc, and Sertoli precursor cells never began to
organize into normal testis cord structures (Figure 3F). These
data indicate that although Fgf9 is not required for the up-
regulation of Sox9 in vivo, it is indispensable to maintain Sox9
expression in Sertoli precursor cells.
Sox9 Is Required for Fgf9 Up-Regulation in XY Gonads
We hypothesized that if the linear relationship among the
three genes were Sry! Fgf9! Sox9, expression of Fgf9 would
be normal in XY gonads in the absence of Sox9. Alternatively,
if the relationship were Sry! Sox9! Fgf9, expression of Fgf9
should be reduced or absent in XY gonads in the absence of
Sox9. We examined Fgf9 expression in Sox9 homozygous
mutant (Sox9D/D) XY gonads generated by crossing mice
Figure 3. Interdependent Relationship between Fgf9 and Sox9
(A–F) Immunostaining of SOX9 (red) in Fgf9þ/ and Fgf9/ XY gonads shows that Fgf9 is required for maintenance of SOX9. The up-regulation of SOX9
in Sertoli precursor cells appears normal in Fgf9/ gonads at 11.5 dpc (D) compared with heterozygous littermate controls (A). However, SOX9 is
detected in fewer cells in mutant gonads at 12.0 dpc (B and E), and is lost by 12.5 dpc (C and F).
(G–J) mRNA whole-mount in situ hybridization for Sry and Fgf9 in Sox9 flox/D and Sox9D/D XY gonads shows that Sox9 is required for Fgf9 expression. Sry
expression is detected in both Sox9 flox/D and Sox9D/D gonads at 11.5 dpc (G and H), whereas Fgf9 expression is markedly decreased or absent in Sox9D/D
gonads at 11.5 dpc (I and J).
(K–O) Comparison of cell proliferation in Sox9D/D versus Sox9 flox/D gonads at 11.5 dpc using immunostaining for phosphorylated histone H3. XY-specific
proliferation at the gonad surface (K) is reduced in the absence of Sox9 (L). Bar graph (O) shows quantitation of proliferation obtained by counting
positive cells in the cortical region of each gonad (right brace) and normalizing to the number obtained from XY Sox9 flox/D gonads. n¼ 30, with five
sections of each gonad and three pairs of gonads for each genotype. PECAM, green (A–F and K–N). The scale bars represent 25 lm.
DOI: 10.1371/journal.pbio.0040187.g003
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homozygous for a conditional null (ﬂox) allele of Sox9
(Sox9ﬂox/ﬂox) with mice carrying germline-speciﬁc Cre trans-
genes, Prm1-Cre in male and Zp3-Cre in female [22,37]. The
Sox9 null mutant embryos die after 11.5 dpc because of
cardiovascular defects [37]. Chaboissier et al. [22] successfully
cultured 11.5 dpc Sox9 null mutant gonads in vitro and
detected male and female markers after 2–3 d of culture,
suggesting that Sox9 mutant gonads are viable and devel-
opmentally competent at 11.5 dpc—the time point at which
we collected samples to perform mRNA in situ hybridization
(Figure 3G–3J). The expression of Fgf9 was signiﬁcantly
decreased or absent in XY Sox9D/D gonads at 11.5 dpc (Figure
3J), while Sry expression was similar to wild-type (Figure 3G
and 3H), as previously reported [20], suggesting that Fgf9
expression in wild-type XY gonads is dependent on the
expression of Sox9. These ﬁndings also indicate that expres-
sion of Sry is not sufﬁcient to regulate Fgf9 in the absence of
Sox9. Therefore, we conclude that Sox9 is essential for Fgf9
expression, and Fgf9, in return, maintains Sox9 expression,
generating a positive feed-forward loop between these two
genes in XY gonads.
Like Fgf9 Mutant Gonads, Sox9D/D XY Gonads Show
Defects in Cell Proliferation
We previously reported that XY-speciﬁc cell proliferation
is defective in Fgf9/ XY gonads [7]. Because Sox9 acts as a
positive regulator of Fgf9 expression, we questioned whether
cell proliferation in XY gonads was also compromised by the
loss of Sox9. We examined proliferation in Sox9D/D gonads at
11.5 dpc using a mitotic cell marker, phosphorylated histone
H3. Proliferating cells were more abundant and concentrated
in a domain near the surface of wild-type XY gonads, and this
XY-speciﬁc cell proliferation was evident in XY Sox9ﬂox/D
littermate controls (Figure 3K). However, in Sox9D/D XY
gonads proliferation was reduced and similar to XX gonads
(Figure 3L–3O). This result supports the idea that there is a
mutual interdependence between Sox9 and Fgf9 generating a
positive feed-forward loop, and that both genes are required
for the expansion of somatic cells, including Sertoli cell
precursors, in XY gonads.
The Male Pathway Is Aborted in Fgf9/ Sertoli Precursors
Based on the fact that Sox9 is initially expressed in Fgf9/
gonads, we investigated whether other genes in the male
pathway are activated. We examined two markers for Sertoli
cell differentiation, anti-Mullerian hormone (Amh) [38] and
Desert hedgehog (Dhh) [39] in Fgf9/ XY gonads using whole-
mount in situ hybridization. Dhh, which is expressed in XY
wild-type and heterozygous gonads beginning at 11.5 dpc, was
absent from Fgf9/ XY gonads, although mesonephric
expression was still detected (Figure 4A and 4B). Amh, which
is a direct transcriptional target of SOX9 activated after 11.5
Figure 4. Sertoli Cell Precursors Switch from Expression of Male to Female Pathway Genes
(A–F) Whole-mount in situ hybridization for genes in the male pathway downstream of Sox9, Dhh, and Amh. Dhh expression is disrupted in XY Fgf9/
gonads (g) at 11.5 dpc (A and B). Amh expression is severely reduced in XY Fgf9/ gonads at 12.5 dpc (E and F).
(G and H) Analysis of cell death in Fgf9/ XY gonads using an apoptotic marker, active caspase-3 (red). No increased apoptosis is observed in XY Fgf9/
gonads (g) compared with control XY gonads, although apoptotic cells are increased around mesonephric tubules (m) of the mutant gonads (arrow in
H). Semitransparent dotted line indicates boundary between mesonephros and gonad. (PECAM, green).
(I–K) Whole-mount in situ hybridization forWnt4, an ovary marker.Wnt4 is expressed in Fgf9/XY gonads at 12.5 dpc (K) similar to the level in XX Fgf9þ/
controls (I) but not in XY controls (J). The scale bars represent 50 lm.
g, gonad; m, mesonephros.
DOI: 10.1371/journal.pbio.0040187.g004
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dpc [38,40], was detected at reduced levels in Fgf9/ XY
gonads at 12.5 dpc (Figure 4C–4F). The residual level of Amh
suggested that the transient expression of SOX9 in Fgf9/
gonads at 11.5 dpc was sufﬁcient to activate Amh, a direct
downstream target. However, the absence of Dhh indicated
that not all Sertoli pathways are initiated.
The initial speciﬁcation of Sertoli cell precursors was not
affected by the loss of Fgf9, as evidenced by normal Sry and
Sox9 expression in Fgf9/ gonads at 11.5 dpc (Figures 2 and
3D). However, SOX9 expression in XY Fgf9/ gonads rapidly
disappeared (Figure 3E and 3F), and other Sertoli markers
were absent or severely reduced (Figure 4A–4F). To inves-
tigate the possibility that this loss was due to cell death, we
immunostained XY Fgf9/ gonads at 12.0 dpc—a time point
at which SOX9-expressing cells were declining in numbers
(Figure 3E)—for active caspase-3, an apoptotic cell marker.
Apoptotic cells were not observed in Fgf9/ gonads or in
littermate controls at 12.0 dpc, although Fgf9/ samples
showed somewhat increased cell death in mesonephric
tubules and ducts, another site of Fgf9 expression (Figure
4G and 4H). These data suggested that the loss of SOX9
expression in Fgf9/ XY gonads was not caused by cell death
but by the disruption of FGF9/SOX9 feed-forward regulation.
To determine whether the aborting of the male pathway in
Fgf9/ Sertoli precursors was associated with the transition of
supporting cells from male to female differentiation, we
investigated expression ofWnt4, an ovary-promoting gene. At
12.5 dpc Wnt4 was up-regulated in XY Fgf9/ but not in XY
Fgf9þ/ gonad controls (Figure 4I–4K). This result suggests that
Fgf9 is necessary for the down-regulation of Wnt4 in differ-
entiating XY gonads at/after bipotential stages.
Fgf9 and Wnt4 Antagonize Each Other
Our ﬁnding that high levels of Wnt4 persist in Fgf9/ XY
gonads implies a genetic antagonism speciﬁcally between Fgf9
and Wnt4, as both SRY and SOX9 are initially expressed in
Fgf9/ XY gonads at 11.5 dpc, yet this is not sufﬁcient to
down-regulate Wnt4. To test whether exogenous FGF9 could
down-regulate expression ofWnt4, we cultured the XX gonad/
mesonephros complex with or without FGF9 protein, and
examined Wnt4 expression by whole-mount in situ hybrid-
ization. Treatment of XX gonads with exogenous FGF9
suppressed the normal expression of Wnt4 (Figure 5A–5C),
supporting the hypothesis that Fgf9, rather than Sry or Sox9,
functions to down-regulate Wnt4 in wild-type XY gonads.
We reasoned that if FGF9 and WNT4 do act as opposing
signals, then reduction in the dose of Wnt4 might render the
XX gonad more susceptible to the male-promoting effects of
exogenous FGF9. To test this possibility, XX Wnt4þ/ and
Wnt4þ/þ gonads were cultured in medium with or without
FGF9, and were examined for SOX9 expression (Figure 5D–
5G). We found that FGF9 induced SOX9 up-regulation in XX
Wnt4þ/ gonads, but not in Wnt4þ/þ XX gonads (Figure 5F and
5G). These results demonstrate antagonism between WNT4
and FGF9 under in vitro gain-of-function conditions. To test
antagonism between these factors under loss-of-function
conditions in vivo, we investigated whether Fgf9 is dere-
pressed in the absence of Wnt4 (Figure 6A–6C). Using an
antibody against FGF9, we found that FGF9 was expressed in
Wnt4/XX gonads but not in Wnt4þ/XX controls (Figure 6B
and 6C). This result suggested that FGF9 is normally down-
regulated by WNT4 in XX gonads.
Given our ﬁnding that FGF9, a positive regulator of Sox9, is
derepressed in XX Wnt4/ gonads, we asked whether
expression of SOX9 might also occur in XX Wnt4/ gonads
(Figure 6D–6L). An antibody against SOX9 revealed that
expression was initially up-regulated in Wnt4/XX gonads at
11.5 dpc (Figure 6F and 6I), although it was rapidly down-
regulated by 12.0 dpc and absent at 12.5 dpc (Figure 6I and
6L). This ﬁnding was conﬁrmed by mRNA in situ hybrid-
ization, which also detected Sox9 transcripts in 11.5 dpc
Wnt4/ XX gonads (Figure S1). Wnt4/ XX gonads do not
increase in size comparable to normal XY gonads (Figure 6C,
6F, 6I, and 6L), and Sertoli cell differentiation and testis cord
formation do not occur. Nevertheless, it is noteworthy that
up-regulation of SOX9 occurs in this case in the absence of
Sry, by eliminating the antagonistic effect of Wnt4 and up-
regulating FGF9, supporting our hypothesis that sex deter-
mination occurs by tipping the balance between these two
opposing signals.
Discussion
Many studies support the view that cells in the undiffer-
entiated gonad are bipotential; the supporting cell precursor
lineage can develop into follicle cells or Sertoli cells. In Fgf9/
XY gonads, cells initially embark on the Sertoli pathway, but
in the absence of Fgf9 can neither maintain Sox9 expression
nor establish downstream male pathways. The loss of Sertoli
cells in XY Fgf9/ gonads is not due to cell death, but instead
Figure 5. Mutual Antagonism between Fgf9 and Wnt4
(A–C)Wnt4 whole-mount in situ hybridization on gonad cultures. Adding
exogenous FGF9 in gonad cultures results in the down-regulation of
Wnt4 expression in cultured XX gonads (C). Controls (A and B) were
cultured without FGF9 peptide.
(D–G) Reduction in the dose of Wnt4 allows FGF9 to induce SOX9 in XX
gonads. Immunostaining of SOX9 (red) shows that addition of FGF9 up-
regulates SOX9 expression in heterozygousWnt4þ/XXgonads (G), but not
in Wnt4þ/þ XX gonads (F). PECAM, green. The scale bars represent 50 lm.
DOI: 10.1371/journal.pbio.0040187.g005
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to a transition of supporting cell fate as SOX9 expression is
lost. We suggest that in the absence of the antagonizing
activity of FGF9, WNT4 signals predominate and govern
somatic cell fate in the gonadal ﬁeld.
The Drosophila genital disk is also a ﬁeld of cells that
normally follows one of two sexually dimorphic fates. For
many years it was believed that the fate of each cell in the
genital disk was under the cell-autonomous control of double
sex (dsx), the key regulator of the sex determination pathway.
However, mosaic studies have shown that the genetic sex of
the cells in the anterior/posterior organizers of the disk, not
the sex of the majority of cells in the disk, regulate the
sexually dimorphic fate of the disk. This occurs through the
sex-speciﬁc regulation of WNT, FGF, and transforming
growth factor beta signaling, which in turn regulate the
growth, cell differentiation, and morphogenesis of the disk
[41,42]. Sex-speciﬁc regulation of gonad organogenesis in
vertebrates may occur in a similar manner, where some cells
are cell-autonomously responsive to the sex-determining
switch; however, the establishment of the male or female
program occurs through the non-cell-autonomous activity of
classic signaling pathways that act in an antagonistic manner
and coordinate growth, cell differentiation and morpho-
genesis in the gonad.
The interplay between cell-autonomous and non-cell-
autonomous pathways in the mammalian gonad is not well
understood. In XX$XY chimera experiments, XX cells can
be recruited to the Sertoli lineage, indicating that non-cell-
autonomous signaling mechanisms operate under these
conditions [15]. Other more recent studies have suggested
that paracrine signals could be involved in the establishment
of Sertoli cells [43–46]. The current study reveals that ectopic
FGF9 can induce SOX9 under conditions in which XX cells
are dissociated (Figure 2F), when an FGF9-coated bead is
directly applied to the XX gonad (Figure 2K), or when the
dose of Wnt4 is reduced (Figure 5G). Whether FGF9 normally
acts non-cell-autonomously in vivo to recruit XY cells to the
Sertoli lineage by up-regulating SOX9 is not clear. We show
that Sry can initially up-regulate SOX9 in the absence of Fgf9,
suggesting that FGF9 is not necessary for this step. However,
FGF9 may act to trigger cell proliferation, increasing the
number of Sertoli precursors above a threshold needed to
stabilize the male pathway, consistent with threshold require-
ments deduced from earlier studies using XX$XY chimeric
gonads [15]. Since Sertoli cells produce FGF9, loss of
proliferation of Sertoli precursors may result in a reduction
of the overall level of FGF9, and/or other male paracrine
signals, below a critical threshold level required to antagonize
the inﬂuence of WNT4. This model is appealing, because it
links cell proliferation, believed to be required for establish-
ment of the male pathway [9], with Sertoli fate determination.
A recent study by Yoshioka et al. [47] showed that
misexpression of Fgf9 in chick nephrogenous mesenchyme
led to the expansion of gonadal marker gene expression,
implicating Fgf9 in gonadal cell proliferation across species.
It has been suggested that SOX9 represses WNT4 based on
misexpression studies [48]. Here we show that the addition of
FGF9 protein to XX gonad explant cultures repressed the
expression of Wnt4. Down-regulation of Wnt4 is unlikely to
occur through SOX9, as SOX9 is not up-regulated in this
situation [7]. Furthermore, although both SRY and SOX9 are
initially expressed in Fgf9/ XY gonads, Wnt4 is not down-
regulated in the absence of Fgf9 (Figure 4K). These ﬁndings
support the idea that FGF9 acts as the antagonist of Wnt4.
Antagonism of WNT signals may be a multistep process
involving both the transcriptional down-regulation of Wnt4
observed in this study and the destabilization of downstream
Wnt intracellular pathways that antagonize SOX9 expression,
as shown in chondrocyte differentiation [49], or that compete
for intracellular signal transducers as has been reported in
other systems [50,51]. Future work will address these
possibilities.
In support of the idea that Wnt4 antagonizes the male
pathway, we found that the loss of Wnt4 caused the up-
regulation of both SOX9 and FGF9 in XX gonads where Sry is
absent. It appears that the male pathway can be initiated by
disrupting the balance between Wnt4 and Fgf9, a ﬁnding that
has strong implications for other vertebrate sex-determina-
tion systems in which Sry is not the sex determining factor.
However, up-regulation of Sox9 is not sufﬁcient to establish
testis development in this mutant, as occurs in Odsex and
other gain-of-function mutants where Sox9 is misexpressed in
the XX gonad [24,25]. In those two misexpression cases, Sox9
expression may have been artiﬁcially sustained by exogenous
regulatory sequences that bypass the ﬁne dosage balance in
this signaling network.
In Wnt4 mutants, SOX9 expression is not maintained. In
light of the observation that the Wnt4/ XX gonad does not
increase signiﬁcantly in size (Figure 6), it is possible that the
Figure 6. Ectopic Expression of Male Factors, SOX9 and FGF9, in XX
Wnt4/ Gonads
(A–C) FGF9 (red) immunostaining shows that FGF9 is expressed in XX
Wnt4/ gonads at 12.5 dpc (C) relative to littermate controls (A and B).
(D–L) SOX9 (red) immunostaining shows that SOX9 is transiently up-
regulated in XX Wnt4/ gonads. SOX9 expression is detected in Wnt4/
XX gonads at 11.5–12.0 dpc (F and I), albeit at reduced levels compared
with XY gonad controls (E-H). SOX9 is not detected in control XX Wnt4þ/
gonads (D-J) or Wnt4/ XX gonads at 12.5 dpc (L). The ectopic coelomic
vessel in XX Wnt4/ gonads [28] is indicated by arrowheads. PECAM,
green. The scale bars represent 50 lm.
DOI: 10.1371/journal.pbio.0040187.g006
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FGF9/SOX9-expressing population did not reach a critical
threshold. Alternatively (or in addition), another male-
speciﬁc factor normally dependent on Sry may be required
to sustain SOX9 expression, possibly FGF-binding proteins in
the extracellular matrix or FGF receptors. It is equally
plausible that there are other female-speciﬁc factors that
antagonize the establishment of SOX9 expression. It has been
observed that several other WNTs are expressed in the XX
gonad [52], and these or other factors may partially
compensate for the loss of Wnt4.
These ﬁndings suggest that WNT4 signaling normally acts
as a repressor of the male pathway by interfering with the up-
regulation of SOX9 expression. One report of a duplication
of the region of human Chromosome 1, which includes
WNT4, led to an intersex phenotype [53]. However, the report
constitutes only circumstantial evidence. Such a role is not
supported by efforts to misexpress Wnt4 in XY gonads, which
have led to very mild phenotypes with no evidence for defects
in Sertoli cell differentiation [54]. It is possible that WNT4
protein did not function as an active signal in these
transgenic mice, either because it was not expressed in the
right cells, at the right time, or at the right level. Consistent
with our data and the partially sex-reversed phenotype of
Wnt4/XX mutants, other WNTs or additional female factors
may be required.
The switch that controls sex determination is biologically
diverse. Sry is not present in nonmammalian systems;
however, antagonistic signaling between FGFs and WNTs
may be the conserved mechanism that balances the gonad
between testicular and ovarian fates in vertebrates. In theory,
any genetic or environmental switch may tip the balance
toward the male pathway. Based on our ﬁndings we propose
that cells in the mammalian gonad are balanced between two
competing cell fates by counterbalanced signaling pathways,
Fgf9, expressed near the coelomic surface, and Wnt4, ex-
pressed near the mesonephric border (Figure 7). In mamma-
lian XY gonads, the onset of Sry expression initiates the male
pathway by up-regulating Sox9. SOX9 up-regulates Fgf9, which
initiates a Sox9/Fgf9 feed-forward loop that accelerates
commitment to the male pathway. In XX gonads or XY
mutant gonads lacking Sry, Sox9, or Fgf9, the SOX9/FGF9 feed-
forward loop is not established, and WNT4 gains control of
the gonadal ﬁeld. This results in the down-regulation of Sox9
and Fgf9, tilting the balance toward commitment to the
female pathway. Further experiments will be required to
deﬁne the molecular mechanism of FGF9 and WNT4 action.
However, our in vivo and in vitro data strongly support the
antagonistic relationship of these two signaling pathways in
regulating expression of the testis-determining factor SOX9.
Materials and Methods
Animals and genotyping. The Fgf9 mutation was maintained on a
C57BL/6 (B6) background that leads to sex reversal in 100% of XY
Fgf9/ offspring. Sry-EGFP mice, a kind gift from K. Albrecht and E.
Eicher, were initially on a mixed B6/129 and were backcrossed to B6
for ﬁve generations. Offspring were then crossed to Fgf9þ/ and
intercrossed and backcrossed to B6 in alternating generations. All XY
Fgf9/ offspring showed complete sex reversal. SryMyc mice were
maintained on a CBA background, and Wnt4 on a mixed 129/SVJ
background. Mutant embryos were sexed by PCR using Y chromo-
some-speciﬁc primers and were genotyped as described [2,16,26,55].
Mice homozygous for the Sox9 deletion were generated using a
germline-speciﬁc gene deletion system as described [20].
In situ hybridization and immunocytochemistry. In situ hybrid-
ization was performed on paraformaldehyde-ﬁxed/OCT embedded
cryosections, as described [56]. Whole-mount in situ hybridization
was performed as previously described [57]. Probes used for in situ
hybridization were: Amh [58], Dhh [20], Wnt4 [8], and Fgf9 [59].
Digoxigenin-labeled probes were prepared according to the Boeh-
ringer-Mannheim-Roche protocol.
Antibodies used in whole-mount immunocytochemistry were:
mouse monoclonal anti-N-MYC (Cell Signaling Technology, Beverly,
Massachusetts, United States; 1:100), rabbit anti-SOX9 (gift of F.
Poulat; 1:1,000), rat anti-PECAM (Pharmingen, San Diego, California,
United States; 1:500), rabbit anti-caspase-3 fragment (BD Bioscience,
San Diego, California, United States; 1:100), and rabbit anti-
phosphorylated histone H3 (Cell Signaling; 1:250). Antibody binding
was detected using ﬂuorophore-conjugated secondary antibodies
(Jackson ImmunoResearch, West Grove, Pennsylvania, United States)
Figure 7. Opposing Signals Regulate Sex Determination in the
Bipotential Gonad
In both XX and XY gonads at 11.25 dpc (15 tail-somite stage), Fgf9
transcripts (white arrows) are detected near the gonad surface (A and B),
whereas Wnt4 transcripts are detected near the gonad mesonephric
boundary (C and D). We propose a model in which the fate of the gonad
is balanced between these competing signals. A genetic or environ-
mental switch initiates the male pathway by creating an imbalance
between these signals. In mammals, this imbalance occurs through the
up-regulation of Sox9. Sox9 up-regulates Fgf9, and Fgf9 maintains Sox9,
forming a positive feed-forward loop in XY gonads. In this situation, the
balance between FGF9 and WNT4 signals is shifted in favor of FGF9, and
the dominance of the male pathway is established. In the absence of a
feed-forward loop between SOX9 and FGF9 (e.g., in XX gonads), WNT4
blocks Fgf9, initiating the female pathway.
DOI: 10.1371/journal.pbio.0040187.g007
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as recommended. For FGF9 immunostaining, gonads were prepared
as frozen sections, and rabbit anti-mouse FGF9 (Cell Science; 1:50)
and anti-rabbit IgG conjugated with peroxidase secondary antibody
were used, followed by ampliﬁcation with tyramide-Cy3 ﬂuorophore
(Molecular Probes, Eugene, Oregon, United States). This antibody did
not detect FGF9 in 12.5 dpc ovary or Fgf9/ null mutant gonads.
Immunostained samples were mounted in DABCO and imaged on a
Zeiss LSM420 confocal microscope.
Primary gonadal cell culture. 11.5 dpc embryos were collected
from CD1 mice, and sex was determined by staining amnions as
described [15]. Whole genital ridges were dissected and gonads were
separated from mesonephroi. The gonads were treated with
collagenase (0.025%) and trypsin (0.025%) in HAT buffer at 37 8C
for 10 min. After the digestion, cells were mechanically dissociated by
pipetting, washed in DMEM, plated on 10-mm diameter coverslips
coated with extracellular matrix (Sigma), and were cultured in DMEM
containing 5% fetal bovine serum and 13 antibiotics/antimycotics at
37 8C, 5% CO2. In one of duplicate cultures, FGF9 (R&D Systems,
Minneapolis, Minnesota, United States) was added to the ﬁnal
concentration of 50 ng/ml in the culture medium. After 36 h of
culture, cells were ﬁxed and immunostained for SOX9. Syto13
(Molecular Probes) was used for nuclear counterstaining, according
to the manufacturer’s instruction.
Gonad explant culture. Gonad/mesonephros complexes were
dissected at 11.5 dpc and cultured on agar blocks for 36 h at 37 8C,
5% CO2 as described [60]. For FGF9 treatment, 50 ng/ml FGF9 (R&D
Systems) was added directly to the culture medium, or an FGF9-
loaded bead was placed on the surface of gonad. To coat beads,
heparin-agarose beads (Sigma, St. Louis, Missouri, United States)
were incubated in 50 lg/ml FGF9 for 2 h, and washed ﬁve times in
culture medium.
Supporting Information
Figure S1. Conﬁrmation that Transcription of Sox9 Is Up-Regulated
in Wnt4/ XX Gonads
Whole-mount in situ hybridization for Sox9 detected Sox9 expression
in 11.5 dpc Wnt4þ/ XY controls and Wnt4/ XX gonads.
Found at DOI: 10.1371/journal.pbio.0040187.sg001 (428 KB PPT).
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